Being on OCREVUS

In 2017, the FDA approved OCREVUS for the treatment of relapsing MS and PPMS. In fact, up until that time, there had not been an approved treatment for PPMS. With OCREVUS, doctors have a different option for treating MS.

Since its approval, thousands of people living with relapsing MS and PPMS have begun their treatment with OCREVUS.

Martha, living with relapsing MS

"I have MS, but MS definitely doesn't have me."

Todd, living with relapsing MS

"I've often called relapsing MS 'a sneaky disease.'"

OCREVUS patient stories

Discover people living with MS who are experiencing fewer maybes.

Be our guest

Sign up to take part in one of our many local and online educational programs. These free programs are designed to support people living with relapsing MS and PPMS.

Get the information and support you need

Sign up to receive information about OCREVUS, along with information that may be helpful throughout the course of your treatment.